Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Smart sustainable bottle (SSB) system for E. coli based recombinant protein production.

Li Z, Carstensen B, Rinas U.

Microb Cell Fact. 2014 Nov 5;13(1):153. [Epub ahead of print]

2.

The metabolic potential of Escherichia coli BL21 in defined and rich medium.

Li Z, Nimtz M, Rinas U.

Microb Cell Fact. 2014 Mar 23;13(1):45. doi: 10.1186/1475-2859-13-45.

3.
4.

Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress.

Ricke-Hoch M, Bultmann I, Stapel B, Condorelli G, Rinas U, Sliwa K, Scherr M, Hilfiker-Kleiner D.

Cardiovasc Res. 2014 Mar 15;101(4):587-96. doi: 10.1093/cvr/cvu010. Epub 2014 Jan 20.

5.

Improving protein delivery of fibroblast growth factor-2 from bacterial inclusion bodies used as cell culture substrates.

Seras-Franzoso J, Peebo K, García-Fruitós E, Vázquez E, Rinas U, Villaverde A.

Acta Biomater. 2014 Mar;10(3):1354-9. doi: 10.1016/j.actbio.2013.12.021. Epub 2013 Dec 19.

PMID:
24361427
6.

Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties.

Gurramkonda C, Zahid M, Nemani SK, Adnan A, Gudi SK, Khanna N, Ebensen T, Lünsdorf H, Guzmán CA, Rinas U.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Dec 1;940:104-11. doi: 10.1016/j.jchromb.2013.09.030. Epub 2013 Sep 27.

PMID:
24141044
7.

Metabolic costs of amino acid and protein production in Escherichia coli.

Kaleta C, Schäuble S, Rinas U, Schuster S.

Biotechnol J. 2013 Sep;8(9):1105-14. doi: 10.1002/biot.201200267. Epub 2013 Jul 15.

PMID:
23744758
8.

Dengue-specific subviral nanoparticles: design, creation and characterization.

Khetarpal N, Poddar A, Nemani SK, Dhar N, Patil A, Negi P, Perween A, Viswanathan R, Lünsdorf H, Tyagi P, Raut R, Arora U, Jain SK, Rinas U, Swaminathan S, Khanna N.

J Nanobiotechnology. 2013 May 25;11:15. doi: 10.1186/1477-3155-11-15.

9.

A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs.

Seras-Franzoso J, Peebo K, Luis Corchero J, Tsimbouri PM, Unzueta U, Rinas U, Dalby MJ, Vazquez E, García-Fruitós E, Villaverde A.

Nanomedicine (Lond). 2013 Oct;8(10):1587-99. doi: 10.2217/nnm.12.188. Epub 2013 Feb 8.

PMID:
23394133
10.

Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies.

Cano-Garrido O, Rodríguez-Carmona E, Díez-Gil C, Vázquez E, Elizondo E, Cubarsi R, Seras-Franzoso J, Corchero JL, Rinas U, Ratera I, Ventosa N, Veciana J, Villaverde A, García-Fruitós E.

Acta Biomater. 2013 Apr;9(4):6134-42. doi: 10.1016/j.actbio.2012.11.033. Epub 2012 Dec 7.

PMID:
23220450
11.

Folding and dimerization kinetics of bone morphogenetic protein-2, a member of the transforming growth factor-β family.

Vallejo LF, Rinas U.

FEBS J. 2013 Jan;280(1):83-92. doi: 10.1111/febs.12051. Epub 2012 Nov 22.

PMID:
23122408
12.

Physiological response of Pichia pastoris GS115 to methanol-induced high level production of the Hepatitis B surface antigen: catabolic adaptation, stress responses, and autophagic processes.

Vanz AL, Lünsdorf H, Adnan A, Nimtz M, Gurramkonda C, Khanna N, Rinas U.

Microb Cell Fact. 2012 Aug 8;11:103. doi: 10.1186/1475-2859-11-103.

13.

Packaging protein drugs as bacterial inclusion bodies for therapeutic applications.

Villaverde A, García-Fruitós E, Rinas U, Seras-Franzoso J, Kosoy A, Corchero JL, Vazquez E.

Microb Cell Fact. 2012 Jun 11;11:76. doi: 10.1186/1475-2859-11-76.

14.

Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies.

Vázquez E, Corchero JL, Burgueño JF, Seras-Franzoso J, Kosoy A, Bosser R, Mendoza R, Martínez-Láinez JM, Rinas U, Fernández E, Ruiz-Avila L, García-Fruitós E, Villaverde A.

Adv Mater. 2012 Apr 3;24(13):1742-7. doi: 10.1002/adma.201104330. Epub 2012 Mar 13.

PMID:
22410789
15.

Inclusion bodies of fuculose-1-phosphate aldolase as stable and reusable biocatalysts.

Sans C, García-Fruitós E, Ferraz RM, González-Montalbán N, Rinas U, López-Santín J, Villaverde A, Álvaro G.

Biotechnol Prog. 2012 Mar-Apr;28(2):421-7. doi: 10.1002/btpr.1518. Epub 2012 Feb 10.

PMID:
22275283
16.

Analysis and Design of Stimulus Response Curves of E. coli.

Kremling A, Goehler A, Jahreis K, Nees M, Auerbach B, Schmidt-Heck W, Kökpinar O, Geffers R, Rinas U, Bettenbrock K.

Metabolites. 2012 Nov 12;2(4):844-71. doi: 10.3390/metabo2040844.

17.

More than just a metabolic regulator--elucidation and validation of new targets of PdhR in Escherichia coli.

Göhler AK, Kökpinar Ö, Schmidt-Heck W, Geffers R, Guthke R, Rinas U, Schuster S, Jahreis K, Kaleta C.

BMC Syst Biol. 2011 Dec 14;5:197. doi: 10.1186/1752-0509-5-197.

18.

Ultra-high-field magnetic resonance enterography in the diagnosis of ileitis (Neo-)terminalis: a prospective study.

Adamek HE, Schantzen W, Rinas U, Goyen M, Ajaj W, Esser C.

J Clin Gastroenterol. 2012 Apr;46(4):311-6. doi: 10.1097/MCG.0b013e31822fec0c.

PMID:
22011584
19.

Optimized procedure to generate heavy isotope and selenomethionine-labeled proteins for structure determination using Escherichia coli-based expression systems.

Li Z, Nimtz M, Rinas U.

Appl Microbiol Biotechnol. 2011 Nov;92(4):823-33. doi: 10.1007/s00253-011-3603-x. Epub 2011 Oct 9.

PMID:
21983707
20.

Recombinant protein purification using gradient assisted simulated moving bed hydrophobic interaction chromatography. Part II: process design and experimental validation.

Gueorguieva L, Palani S, Rinas U, Jayaraman G, Seidel-Morgenstern A.

J Chromatogr A. 2011 Sep 16;1218(37):6402-11. doi: 10.1016/j.chroma.2011.07.008. Epub 2011 Jul 18.

PMID:
21824621
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk